Abstract
Leukocyte trafficking from bloodstream to tissue is important for the continuous surveillance for foreign antigens, as well as for rapid leukocyte accumulation at sites of inflammatory response or tissue injury. Leukocyte interaction with vascular endothelial cells is a pivotal event in the inflammatory response and is mediated by several families of adhesion molecules. The crucial role of the β 2-integrin subfamily in leukocyte emigration was established after leukocyte adhesion deficiency (LAD) I was discovered. Patients with this disorder suffer from life-threatening bacterial infections, and in its severe form, death usually occurs in early childhood unless bone marrow transplantation is performed. The LAD II disorder clarifies the role of the selectin receptors and their fucosylated ligands. Clinically, patients with LAD II suffer from a less severe form of disease, resembling the moderate phenotype of LAD I. LAD III emphasizes the importance of the integrin activation phase in the adhesion cascade. Although the primary defect is still unknown, it is clear that all hematopoietic integrin activation processes are defective, which lead to severe infection as observed in LAD I and to marked increase tendency for bleeding problems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alon, R., Aker, M., Feigelson, S., Sokolovsky-Eisenberg, M., Staunton, D.E., Cinamon, G., Grabovsky, V., Shamri, R. and Etzioni, A. (2003) A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 101, 4437–4445.
Alon, R. and Etzioni, A. (2003) LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 24, 561–566.
Anderson, D.C. and Smith, C.W. (2001). Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. New York, McGraw-Hill.
Bauer, T.R., Jr., Hai, M., Tuschong, L.M., Burkholder, T.H., Gu, Y.C., Sokolic, R.A., Ferguson, C., Dunbar, C.E. and Hickstein, D.D. (2006) Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood 108, 3313–3320.
Bauer, T.R., Jr. and Hickstein, D.D. (2000) Gene therapy for leukocyte adhesion deficiency. Curr. Opin. Mol. Ther. 2, 383–388.
Bos, J.L., de Rooij, J. and Reedquist, K.A. (2001) Rap1 signalling: adhering to new models. Nat. Rev. Mol. Cell. Biol. 2, 369–377.
Crittenden, J.R., Bergmeier, W., Zhang, Y., Piffath, C.L., Liang, Y., Wagner, D.D., Housman, D.E. and Graybiel, A.M. (2004) CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat. Med. 10, 982–986.
Etzioni, A. (1996) Adhesion molecules- role in health and disease. Pediat. Res. 39, 191–198.
Etzioni, A., Frydman, M., Pollack, S., Avidor, I., Phillips, M.L., Paulson, J.C. and Gershoni-Baruch, R. (1992) Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 327, 1789–1792.
Etzioni, A., Gershoni-Baruch, R., Pollack, S. and Shehadeh, N. (1998) Leukocyte adhesion deficiency type II: long-term follow-up. J. Allergy Clin. Immunol. 102, 323–324.
Etzioni, A. and Tonetti, M. (2000) Fucose supplementation in leukocyte adhesion deficiency type II. Blood 95, 3641–3643.
Fischer, A., Lisowska-Grospierre, B., Anderson, D. and Springer, T. (1988) Leukocyte adhesion deficiency: molecular basis and functional consequences. Immunol. Rev. 1, 39–54.
Harris, E.S., Shigeoka, A.O., Li, W., Adams, R.H., Prescott, S.M., McIntyre, T.M., Zimmerman, G.A. and Lorant, D.E. (2001) A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by β 1 and β 2 integrins. Blood 97, 767–776.
Helmus, Y., Denecke, J., Yakubenia, S., Robinson, P., Luhn, K., Watson, D.L., McGrogan, P.J., Vestweber, D., Marquardt, T. and Wild, M.K. (2006) Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood 107, 3959–3966.
Hogg, N., Stewart, M.P., Scarth, S.L., Newton, R., Shaw, J.M., Law, S.K. and Klein, N. (1999) A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J. Clin. Invest. 103, 97–106.
Karsan, A., Cornejo, C.J., Winn, R.K., Schwartz, B.R., Way, W., Lannir, N., Gershoni-Baruch, R., Etzioni, A., Ochs, H.D. and Harlan, J.M. (1998) Leukocyte adhesion deficiency type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium. J. Clin. Invest. 101, 2438–2445.
Kinashi, T. (2005) Intracellular signalling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 5, 546–559.
Kinashi, T., Aker, M., Sokolovsky-Eisenberg, M., Grabovsky, V., Tanaka, C., Shamri, R., Feigelson, S., Etzioni, A. and Alon, R. (2004) LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 103, 1033–1036.
Kuijpers, T.W., Van Lier, R.A., Hamann, D., de Boer, M., Thung, L.Y., Weening, R.S., Verhoeven, A.J. and Roos, D. (1997) Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J. Clin. Invest. 100, 1725–1733.
Lorusso, F., Kong, D., Jalil, A.K., Sylvestre, C., Tan, S.L. and Ao, A. (2006) Preimplantation genetic diagnosis of leukocyte adhesion deficiency type I. Fertil. Steril. 85, 494 e415–e498.
Lubke, T., Marquardt, T., Etzioni, A., Hartmann, E., von Figura, K. and Korner, C. (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28, 73–76.
Lubke, T., Marquardt, T., von Figura, K. and Korner, C. (1999) A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi. J. Biol. Chem. 274, 25986–25989.
Luo, Y. and Haltiwanger, R.S. (2005) O-fucosylation of notch occurs in the endoplasmic reticulum. J. Biol. Chem. 280, 11289–11294.
Luster, A.D., Alon, R. and von Andrian, U.H. (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182–1190.
Marquardt, T., Luhn, K., Srikrishna, G., Freeze, H., Harms, E. and Vestweber, D. (1999) Correction of LAD type II with oral fucose. Blood 94, 3976–3985.
McDowall, A., Inwald, D., Leitinger, B., Jones, A., Liesner, R., Klein, N. and Hogg, N. (2003) A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins. J Clin. Invest. 111, 51–60.
Roos, D., Meischl, C., de Boer, M., Simsek, S., Weening, R.S., Sanal, O., Tezcan, I., Gungor, T. and Law, S.K. (2002) Genetic analysis of patients with leukocyte adhesion deficiency: genomic sequencing reveals otherwise undetectable mutations. Exp. Hemat. 30, 252–261.
Shamri, R., Grabovsky, V., Gauguet, J.M., Feigelson, S., Manevich, E., Kolanus, W., Robinson, M.K., Staunton, D.E., von Andrian, U.H. and Alon, R. (2005) Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 6, 497–506.
Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314.
Sturla, L., Rampal, R., Haltiwanger, R.S., Fruscione, F., Etzioni, A. and Tonetti, M. (2003) Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc). J. Biol. Chem. 278, 26727–26733.
Thomas, C., Le Deist, F., Cavazzana-Calvo, M., Benkerrou, M., Haddad, E., Blanche, S., Hartmann, W., Friedrich, W. and Fischer, A. (1995) Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 86, 1629–1635.
Tone, Y., Wada, T., Shibata, F., Toma, T., Hashida, Y., Kasahara, Y., Koizumi, S. and Yachie, A. (2007) Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood 109, 1182–1184.
von Andrian, U.H., Berger, E.M., Ramezani, L., Chambers, J.D., Ochs, H.D., Harlan, J.M., Paulson, J.C., Etzioni, A. and Arfors, K.E. (1993) In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J. Clin. Invest. 91, 2893–2897.
von Andrian, U.H. and Mackay, C.R. (2000) T cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343, 1020–1034.
Wild, M.K., Luhn, K., Marquardt, T. and Vestweber, D. (2002) Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs 172, 161–173.
Yakubenia, S. and Wild, M.K. (2006) Leukocyte adhesion deficiency II. Advances and open questions. FEBS J. 273, 4390–4398.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Etzioni, A. (2007). Leukocyte Adhesion Deficiencies: Molecular Basis, Clinical Findings, and Therapeutic Options. In: Shurin, M.R., Smolkin, Y.S. (eds) Immune-Mediated Diseases. Advances in Experimental Medicine and Biology, vol 601. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72005-0_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-72005-0_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72004-3
Online ISBN: 978-0-387-72005-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)